Exagen Inc. Files 8-K: Material Agreement, Other Events
Ticker: XGN · Form: 8-K · Filed: May 8, 2025 · CIK: 1274737
| Field | Detail |
|---|---|
| Company | Exagen Inc. (XGN) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-event, filing
TL;DR
EXAGEN files 8-K for material agreement & other events. Details TBD.
AI Summary
Exagen Inc. filed an 8-K on May 8, 2025, reporting on events that occurred on May 7, 2025. The filing indicates the entry into a material definitive agreement, other events, and the submission of financial statements and exhibits. Specific details regarding the agreement or financial figures were not immediately available in the provided text.
Why It Matters
This 8-K filing signals significant corporate activity for Exagen Inc., potentially involving new business agreements or financial updates that could impact investors.
Risk Assessment
Risk Level: medium — The filing of an 8-K often indicates material events, but the lack of specific details in the provided text necessitates a medium risk assessment until more information is disclosed.
Key Numbers
- May 7, 2025 — Date of earliest event (Reporting date for the 8-K)
- May 8, 2025 — Filing date (Date the 8-K was submitted)
Key Players & Entities
- EXAGEN INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-39049 (company_id) — Commission File Number
- 20-0434866 (tax_id) — IRS Employer Identification No.
- 1261 Liberty Way Vista, CA 92081 (address) — Principal executive offices
- (760) 560-1501 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement entered into by Exagen Inc.?
The provided text does not specify the details of the material definitive agreement.
What are the 'Other Events' reported in the 8-K filing?
The specific 'Other Events' are not detailed in the provided excerpt.
What financial statements and exhibits are being filed with this 8-K?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was Exagen Inc. incorporated, and in which state?
Exagen Inc. was incorporated in Delaware.
What is Exagen Inc.'s principal executive office address and phone number?
Exagen Inc.'s principal executive office is located at 1261 Liberty Way Vista, CA 92081, and its phone number is (760) 560-1501.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding EXAGEN INC. (XGN).